Investing Profile

Barbara Dalton

VCInvestor
President at SROne
Photo of Barbara Dalton, President at SROne

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Pfizer Network
79 CONNECTIONS
Pfizer Network
79 CONNECTIONS
cb
SROne President
$100K - $15.0M
$10.0M
9
CompanyStageDateRound SizeTotal Raised
Artios Pharma
Series DNov 2025$120M
Series CJul 2021$150M
Series BAug 2018$83M
$380M
Co-investors: Hakan Goker (MDC Ventures (formerly KBS Ventures)), René Kuijten (EQT Group), Florian Müllershausen (Novartis Venture Fund), Raphael Wisniewski (Andera Partners), Nikola Trbovic (Pfizer Venture Investments), Jake Simson (RA Capital Management)
Complexa
Series CJul 2017$62M
$62M
Co-investors: Ven Raju (Innovation Works), Sara Nayeem (Avoro Ventures), David Mott (Mott Family Capital), Peter Erin (Riverfront Ventures)
Ixchelsis
Series UnknownDec 2016$12M
$12M
Cydan
Series UnknownApr 2013$16M
$60M
Co-investors: David Mott (Mott Family Capital)
Rhythm Pharmaceuticals
Series BNov 2012$33M
$110M
Co-investors: Ed Mathers (New Enterprise Associates (NEA)), Steven St. Peter (T1D Fund)
Ablexis
Series AJun 2010$12M
$12M
Co-investors: Lou Tartaglia (Third Rock Ventures), Cary Pfeffer (Third Rock Ventures)
Flexion Therapeutics
Series AJan 2010$9M
$62M
Co-investors: Andrew Schwab (5am Ventures), Heath Lukatch (Novo Holdings)
President daffodil.aiPresent
President SROnePresent
Senior Managing Partner, Pfizer Ventures; Vp, Worldwide Business Development, Pfizer Inc PfizerPresent
Partner EuclidSR PartnersPresent
Senior Managing Partner, Pfizer Ventures; VP, Worldwide Business Development, Pfizer Inc PfizerPresent
Drexel University College of Medicine doctorates, doctor of philosophy microbiology, immunology
The Medical College of Pa (now Drexel University College of Medicine) PhD Microbiology/Immunology
Sign in with Google →
Sign in with Google →